Cash Strategies for Life Sciences Delays
By Andrew Levitch
The one constant when raising financing in a life sciences company is that it takes longer than initially forecasted. As previously shared in my colleague Patrick Nugent’s article about Life Sciences Financing Trends, it is taking twice as long to close a financing round (six months or more), and the length of time…Read More
Read MoreWhy CFOs Must Rethink Marketing ROI in the Age of AI Search
By Eric Mersch
Over the past five years, I have increasingly focused on working with executive teams, specifically Chief Revenue Officers, to improve clients’ Go-to-Market (GTM) strategies. The end of the zero interest rate period (ZIRP) and the rise of Generative AI have made the sales process much more complex. I’m finding that…Read More
Read MoreEssential Lessons for Becoming an Interim CFO and Excelling in Leadership
By FLG Partners
Stepping into the role of an interim CFO is not just about crunching numbers; it’s about navigating complexity, providing strategic clarity, and becoming a critical advisor. Whether tackling crises or driving organizational transitions, interim CFOs wield influence far beyond traditional financial oversight. More directly stated, “You need to have the…Read More
Read MoreWhat’s Your Leadership Style—and Is It Effective?
By Stephanie Roberts
I’ve asked myself these questions more than once throughout my career: What’s my leadership style? And is it actually effective? They sound simple, but they require reflection, honesty, and time. We’re each uniquely qualified to examine the experiences that shaped how we lead. I’ll share how my leadership style formed,…Read More
Read More